# Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne

> **NCT01701024** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 498 (actual)

## Conditions studied

- Acne

## Interventions

- **DRUG:** ACYC
- **DRUG:** ACYC vehicle

## Key facts

- **NCT ID:** NCT01701024
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-05
- **Final completion:** 2013-07
- **Target enrollment:** 498 (ACTUAL)
- **Last updated:** 2018-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01701024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01701024, "Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01701024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*